$-0.79
(Market cap
$346 Mln
Revenue (TTM)
$76 Mln
P/E Ratio
--
P/B Ratio
41
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-17.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-6.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.5
-
Face value
--
-
Shares outstanding
30,926,847
10 Years Aggregate
CFO
$-168.37 Mln
EBITDA
$-188.33 Mln
Net Profit
$-182.45 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Avita Medical - ADR
| 201.7 | 34.0 | 149.0 | 144.4 | -12.9 | -12.2 | 5.0 |
|
BSE Sensex*
| -11.7 | -4.8 | 1.7 | -7.5 | 3.9 | 5.1 | 9.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Avita Medical - ADR
| -73.0 | -6.7 | 107.9 | -44.9 | -35.5 | -59.2 | 697.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Avita Medical - ADR
|
10.4 | 346.4 | 75.6 | -43.1 | -49.8 | -- | -- | 41.0 |
| 85.1 | 12,161.6 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.2 | |
| 270.1 | 17,746.8 | 1,054.4 | 755.9 | 5.7 | -- | 20.9 | 10.5 | |
| 75.4 | 10,109.8 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.5 | |
| 57.7 | 14,621.6 | 2,435.9 | 860.6 | 31.0 | 43 | 18.6 | 7.9 | |
| 108.3 | 12,506.3 | 1,663.7 | 413.6 | 36.3 | 430 | 32.3 | 86.7 | |
| 351.3 | 10,603.5 | 440.5 | 241.5 | 33.4 | 18.7 | 44.9 | 8.1 | |
| 116.5 | 9,761.1 | 105.0 | -299.7 | -227.2 | -19.4 | -- | 6.5 | |
| 534.2 | 12,501.2 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 23.9 | |
| 590.9 | 16,503.9 | 2,782.3 | 491.5 | 21.1 | 110.1 | 34.7 | 38.2 |
Shareholding Pattern
View DetailsAbout Avita Medical - ADR
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell... harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California. Read more
-
CEO, President & Executive Director
Mr. James M. Corbett
-
CEO, President & Executive Director
Mr. James M. Corbett
-
Headquarters
Valencia, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Avita Medical - ADR
What is the current share price of Avita Medical Inc - ADR Today?
The share price of Avita Medical Inc - ADR is $10.41 (NASDAQ) as of 08-Sep-2026 16:00 EDT. Avita Medical Inc - ADR has given a return of -12.91% in the last 3 years.
What is the current PB & PE ratio of Avita Medical Inc - ADR?
Since, TTM earnings of Avita Medical Inc - ADR is negative, P/E ratio is not available.
The P/B ratio of Avita Medical Inc - ADR is 40.95 times as on 04-Sep-2026, a 668 premium to its peers’ median range of 5.33 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-2.16 |
-6.30 |
2024 |
-5.41 |
74.39 |
2023 |
-9.88 |
7.13 |
2023 |
-0.43 |
0.14 |
2022 |
-6.21 |
1.95 |
What is the 52 Week High and Low of Avita Medical Inc - ADR?
The 52-week high and low of Avita Medical Inc - ADR are Rs 11.39 and Rs 3.22 as of 09-Sep-2026.
What is the market cap of Avita Medical Inc - ADR?
Avita Medical Inc - ADR has a market capitalisation of $ 346 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Avita Medical Inc - ADR?
Before investing in Avita Medical Inc - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.